Using ctDNA to Predict Cancer Recurrence and Guide Therapy Selection

A ctDNA testing method has the capability to predict cancer recurrence, which could help guide therapy selections and uncover new drug development opportunities.

from Latest articles from Cancer Therapy Advisor Breast Cancer https://ift.tt/2R2b4M7
إرسال تعليق (0)
أحدث أقدم